Feature of Ocular-Ischemic Syndrome in Patients with Cardiovascular Pathology. Literature Review

Author:

Frolov M. A.1,Sakhovskaya N. A.1,Frolov A. M.1,Pryamikov A. D.2

Affiliation:

1. Peoples Friendship University

2. Moscow clinical hospital named after V.M. Buyanov

Abstract

Vascular pathology of the vision organ is one of the leading causes of irreversible vision loss. Ocular ischemic syndrome is a serious condition that requires special attention to prevent adverse effects and outcomes. Today, this syndrome mainly occurs in the form of ischemic optic neuropathy and chronic ischemic retinopathy, which are based on damage caused by impaired perfusion in the pool of the ophthalmic artery. According to the data presented in foreign and domestic literature, there is an correlation between the ocular ischemic syndrome and the pathology of the cardiovascular system. Often, this pathology is accompanied by such diseases as: coronary heart disease, atherosclerosis, arterial hypertension, and diabetes mellitus. A number of studies have shown that an important risk factor for the development of vascular eye’s pathology is the combination of coronary heart disease with elevated total blood cholesterol and atherosclerosis in combination with arterial hypertension. Also, there are data indicating the association of the risk of ischemic opticopathy with the presence of cardiovascular diseases in patients, and vice versa, previously transferred opticopathy can be considered as predictors of cardiovascular pathology. Thus, prevention and treatment of this pathology is an interdisciplinary problem. The classical approach in the treatment of ocular ischemic syndrome today remains conservative therapy, which aims to reduce local ischemia and the effects of hypoxia. However, conservative treatment does not eliminate the main reason for the development of this condition; therefore, the search continues for new, more effective methods of preventing and treating this pathology. In recent years, data on high clinical efficacy in the treatment and prevention of ocular ischemic syndrome manifestations have appeared in the literature after surgery to restore the main blood flow at the level of the brachiocephalic arteries. A variety of cardiovascular diseases and various levels of its damage determine the approach to the treatment of this pathology. This literature review is devoted to the analysis of the causes of ocular ischemic syndrome, depending on the level of localization of the lesion of the cardiovascular system.

Publisher

PE Polunina Elizareta Gennadievna

Subject

Ophthalmology

Reference60 articles.

1. Hayreh S.S. Factors influencing blood flow in the optic nerve head. J Glaucoma. 1997 Dec;6(6):412–425. PMID: 9407371

2. Wong T.Y. Retinal arteriolar emboli: epidemiology and risk of stroke. Curr Opin Ophthalmol. 2002 Jun;13(3):142–146.

3. Oshchepkova E.V., Efremova Yu.E., Karpov Yu.A. Zabolevaemost' i smertnost' ot infarkta miokarda v Rossiiskoi Federatsii v 2000–2011 gg. Terapevticheskii arkhiv. 2013;4:4–10. [Oshhepkova E.V., Efremova Yu.E., Karpov Yu.A. Morbidity and mortality from myocardial infarction in the Russian Federation in 2000–2011. Therapeutic Archive = Terapevticheskiy arkhiv. 2013;4:4–10 (In Russ.)].

4. Chen K.J., Chen S.N., Kao L.Y., Ho C.L, Chen T.L., Lai C.C., Wu S.C. Ocular ischemic syndrome. Chang Gung Medical Journal. 2001 Aug;24(8):483–491.

5. Hazin R., Daoud Y.J., Khan F. Ocular ischemic syndrome: recent trends in medical management. Curr Opin Ophthalmol. 2009 Nov;20(6):430–433. DOI: 10.1097/ICU.0b013e3283313d38

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3